Search for articles or Rx savings
Key takeaways
Gemtesa is a brand-name drug with a retail price of about $689 per month for 30, 75 mg tablets.
A generic form of Gemtesa will not become available until the early 2030s.
Generic antimuscarinic drugs such as oxybutynin, mirabegron ER, and tolterodine are more affordable, but they may cause different side effects than Gemtesa.
Overactive bladder (OAB) can cause urinary frequency, urinary urgency, and even leakage (urinary incontinence). Gemtesa (vibegron) is a beta-3 adrenergic agonist approved by the Food and Drug Administration (FDA) to treat OAB symptoms. However, the retail price of about $689 for 30, 75 mg tablets of brand-name Gemtesa tablets can be prohibitively expensive without insurance coverage or coupons. Many people turn to generic drugs for lower prices, but that only works when a drug is available in generic form.
Is a generic for Gemtesa available?
“At this time, there is not a generic form of the medication available,” says JaLorean Hayes, a registered nurse, public health consultant, and founder of Hayes Global Health Strategies. “Gemtesa currently has a number of patents in place that prevent other [manufacturers] from being able to make a medication with the same mechanism of action.”
So, when will generic Gemtesa become available? Not anytime soon. “Most new drugs are protected by patents for about 10–15 years after approval,” says Barbara Sparacino, MD, a triple board-certified physician and founder of The Aging Parent Coach. “Gemtesa was FDA approved in 2020, so we likely won’t see a generic available until the early 2030s unless a patent challenge or licensing deal accelerates the timeline.”
Affordable Gemtesa alternatives
Gemtesa isn’t the only FDA-approved treatment for overactive bladder symptoms. If you’re struggling to afford your prescription, there are several alternatives you can ask your prescriber about.
The most obvious Gemtesa alternative is Myrbetriq (mirabegron ER), another beta-3 agonist with the same mechanism of action. Both Gemtesa and Myrbetriq increase urinary retention by relaxing the bladder detrusor muscle. This helps combat OAB symptoms, but it also increases the risk of urinary tract infection (UTI). The average retail price of Myrbetriq is $625 for 30, 50 mg tablets, which is about $60 lower than Gemtesa. But Dr. Sparacino points out that it is still a “costly” drug without insurance coverage. Thankfully, a generic version of Myrbetriq (mirabegron) was made available in 2024 and costs as little as $187 for 30, 50 mg extended-release tablets with a SingleCare prescription discount card or coupon.
According to Hayes, there are other affordable alternatives to Gemtesa, including antimuscarinic medications that are available in generic form. Antimuscarinic drugs also work by helping the bladder muscles relax, but common side effects include dry mouth, constipation, drowsiness, and blurred vision. Without insurance coverage, generic antimuscarinic prices range from $105 to $404 per month—much lower than Gemtesa’s cost of $678 per month.
Compare Gemtesa alternatives |
||||
|---|---|---|---|---|
| Drug name | Drug class | Average retail price without insurance* | SingleCare price* | How to save |
| Mirabegron | Beta-3 adrenergic agonist | $665 for 30, 50 mg extended-release tablets | $187 for 30, 50 mg extended-release tablets | Get coupon |
| Fesoterodine fumarate ER | Antimuscarinic | $406 for 30, 8 mg extended-release tablets | $36 for 30, 8 mg extended-release tablets | Get coupon |
| Solifenacin succinate | Antimuscarinic | $369 for 30, 10 mg tablets | $16 for 30, 10 mg tablets | Get coupon |
| Oxybutynin extended-release (ER) | Antispasmodic | $104 for 30, 10 mg tablets | $10 for 30, 10 mg tablets | Get coupon |
| Tolterodine tartrate | Antimuscarinic | $105 for 30, 2 mg tablets | $14 for 30, 2 mg tablets | Get coupon |
*Prices fluctuate and vary by pharmacy and location. These are the most recent prices as of the time of publication.
How to save on Gemtesa
“Because Gemtesa is a newer, brand-name medication without a generic alternative, the cost is a significant barrier,” Dr. Sparacino says. Fortunately, healthcare professionals understand that financial strain can impact your ability to stick to your prescription drug plan. It’s a good idea to tell your healthcare provider if you struggle to afford your prescription. You may not know the out-of-pocket cost until you get to the pharmacy for medication pick-up. Your healthcare provider can offer medical advice on the best treatment for overactive bladder, even if it is a Gemtesa alternative, taking into consideration other medical conditions, history of serious side effects or allergic reactions, and possible drug interactions with other medications or supplements you may be taking.
If your prescriber determines that Gemtesa is still the best treatment for you, there are still ways to save. One savings tip is to use a SingleCare prescription discount card or Gemtesa coupon, which can lower the out-of-pocket cost of Gemtesa to $427 for 30, 75 mg tablets at participating pharmacies. Simply go to the SingleCare website homepage and type in the name of your prescription to compare drug prices and have free coupons texted or emailed to you.
- Highlights of prescribing information, Food and Drug Administration (2025)
- Mirabegron, StatPearls (2023)
- Basic and clinical aspects of antimuscarinic agents used to treat overactive bladder, Pharmacology and Therapeutics (2018)